ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Adult-to-Adult Living Donor Liver Transplantation in Acute Liver Failure – Do Outcomes Justify the Risks?

A. Shingina1, I. A. Ziogas2, P. Vutien3, E. Uleryk4, E. Renner5, M. P. Bhat6, J. Tinmouth4, J. Kim7

1Vanderbilt University, Nashville, TN, 2Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, 3University of Washington Medical Center, Seattle, WA, 4University of Toronto, Toronto, ON, Canada, 5University of Manitoba, Saskatchewan, MB, Canada, 6Multi-Organ Transplant, UHN, Toronto, ON, Canada, 7Toronto General Hospital, Toronto, ON, Canada

Meeting: 2022 American Transplant Congress

Abstract number: 1768

Keywords: Liver failure, Living donor, Living-related liver donors, Survival

Topic: Clinical Science » Liver » 58 - Liver: Living Donor Liver Transplant and Partial Grafts

Session Information

Session Name: Liver: Living Donor Liver Transplant and Partial Grafts

Session Type: Poster Abstract

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Living-donor Liver Transplantation(LDLT) has emerged as a safe and effective alternative in children and adults with pre-existing liver diseases. Utilization of LDLT for patients with acute liver failure has been limited by concerns regarding donor safety, donor consent process and recipient outcomes. Our objective was to conduct a systematic review and meta-analysis to investigate whether the concerns about subpar LDLT outcomes in patients with ALF are justified.

*Methods: We followed the PRISMA statement checklist conducted database searches in MEDLINE, Medline-in-Process, Medline Epub Ahead of Print and EMBASE + EMBASE Classic (OvidSP); and Cochrane (Wiley) on August 27, 2021. United Network for Organ Sharing (UNOS) database Standard Transplant Analysis and Research data file (released July 28, 2021) was queried for patients over the age of 18, that underwent liver transplantation for “status 1”.

*Results: Of 427 articles reviewed, 3 studies comprising 2533 patients (155 underwent LDLT and 2376 DDLT), were included in the meta-analysis. One, 3,5-year patient and graft survival demonstrated no difference between LDLT and DDLT group: 1-year patient survival OR1.51; 95%CI [0.58,1.90]; 1-year graft survival OR 1.19; 95%CI [0.65-2.18]; 3-year patient survival OR 0.97;95%CI [0.52-1.88]; 3-year graft survival OR 1.21 95%CI [0.67-2.16]; 5-year patient survival 0.9; 95%CI [0.37-2.20]; 5-year graft survival OR 1.30; 95%CI [0.57-2.97]. UNOS database search returned only 3 patients that underwent LDLT for ALF compared to 1562 with DDLT precluding comparison.

*Conclusions: One, 3, and 5-year patient and graft survival following LDLT vs DDLT transplantation were not statistically significantly different; however, due to limited number of studies further studies are warranted.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Shingina A, Ziogas IA, Vutien P, Uleryk E, Renner E, Bhat MP, Tinmouth J, Kim J. Adult-to-Adult Living Donor Liver Transplantation in Acute Liver Failure – Do Outcomes Justify the Risks? [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/adult-to-adult-living-donor-liver-transplantation-in-acute-liver-failure-do-outcomes-justify-the-risks/. Accessed May 28, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences